Avesthagen Limited To Manufacture Bioactives For Ayurvedic Drugs

November 27th, 2008 by Vikas Sharma Leave a reply »

AVESTHAGEN LIMITED, India’s leading life sciences company that focuses on the convergence of food, pharma and population genetics leading to predictive, preventive, personalized healthcare has been granted a license to manufacture bioactives for Ayurvedic Drugs by the Drugs Licensing Authority, under the Department of AYUSH, Ministry of Health & Family Welfare, Government of India. This license will help Avesthagen to tap into the huge Indian Ayurvedic market and the growing global market of Ayurvedic products.

Dr. Villoo Morawala Patell, Founder, Chairman and Managing Director of AVESTHAGEN LIMITED said “This license is proof that our research & development activities are reaping results. This significant milestone has opened a large market for us offering a great opportunity for growth. Ayurveda is one of the oldest health care systems in India, and this is a great opportunity for us to popularize the system internationally.”

The Ayurvedic industry, recorded annual sales of about Rs 7,000 crore in fiscal 2008. Ayurvedic ingredients, have been used in Indian healthcare and cosmetics products for centuries, are becoming increasingly popular in the West as the trend for natural and more holistic products continues. According to market research analysts, Indian Ayurvedic firms have the potential to strike $120 Billion in the global Herbal Market, and also have the potential to export them.

AVESTHAGEN LIMITED’S bioactive manufacturing unit, Dhanvantari Botanicals Pvt. Ltd., located near Bangalore, India is an ISO 9001:2000 certified unit. It is also one of the first few bioactive manufacturing units across the world to achieve ISO 22000-2005 and “Certified Organic” for processing. This facility is spread over 50,000 square feet with a state-of-the-art production and a R&D facility. The herbal extract manufacturing unit is the first of its kind in Karnataka with a certification by the Indian System of Medicine and Homeopathy to manufacture 43 bioactives as Ayurvedic products.

This bioactive manufacturing unit adheres to very stringent quality control and quality assurance norms. The quality and food safety management systems at this unit ensure production of high quality botanical extracts at competitive prices. To ensure no slippage in manufacturing, the unit employs a very competitive staff.

Random Ayurveda News

  • Fumigation of herbal drugs in Thrissur today (0)
    THRISSUR: The Thrissur Corporation and the district unit of the Ayurveda Medical Association of India will jointly organise an eco-friendly and bio-medical method of disease prevention by fumigation of herbal drugs prescribed in Ayurvedic texts - dho...
  • Protecting India’s Traditional Knowledge from Patent Piracy (3)
    The government of India has granted the European Patent Office (EPO) access to its Traditional Knowledge Digital Library (TKDL). Loaded with ancient medical knowledge, the online database contains translations of manuscripts and textbooks in five lan...
  • AYUSH geared well to encourage Ayurveda and Siddha (1)
    In order to uplift Ayurveda and Siddha system of treatment the centre has decided to take initiative to launch a campaign to aware people of such age old modes of treatment especially for elderly people. The campaign is aimed at generating awareness ...
  • Dabur eyes rural areas for baby care market (0)
    AyurvedNews.Com, April 1, 2008: Dabur India is relying on the country`s rural and semi-urban areas for growth in the baby care segment, reports Business Standard. The rural and semi-urban areas accounts for nearly 60% of the company`s sales in the...
Advertisement

Leave a Reply